Benzinga

Benzinga

Benzinga

lunes, agosto 24

Rallybio Corp

RLYBNASDAQ
Trade with Public
Trade with Public
$16.83
al cierre: Aug 24, 5:00 PM EST
$17.19
0.362.14%
After hour: Aug 19, 9:12 AM EST
Panorámica generalNoticiasPrevisión de beneficiosEventosPrecios objetivoFinanzasSentimientoPropiedadCompararInforme de acciones

Rallybio Financials

Rallybio (RLYB) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
UPDATE: Rallybio Q3 Adj. EPS $(0.14) Beats $(0.21) Estimate, Sales $212.000K Beat $66.667K Estimate

Rallybio (NASDAQ:RLYB) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.21) by 34.58 percent. This is a 46.15 percent increase over losses of $(0.26) per share from the same
Benzinga Newsdesk

PRO
Rallybio Q3 EPS $0.36 Beats $(0.21) Estimate, Sales $212.000K Beat $66.667K Estimate

Rallybio (NASDAQ:RLYB) reported quarterly earnings of $0.36 per share which beat the analyst consensus estimate of $(0.21) by 269.01 percent. This is a 238.46 percent increase over losses of $(0.26) per share from the
Benzinga Newsdesk

PRO
Rallybio Q2 EPS $(0.22) Beats $(0.24) Estimate, Sales $212.000K Down From $299.000K YoY

Rallybio (NASDAQ:RLYB) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.24) by 10.2 percent. This is a 40.54 percent increase over losses of $(0.37) per share from the same
Benzinga Newsdesk

PRO
Rallybio Q1 EPS $(0.21) Beats $(0.26) Estimate, Sales $212.00K

Rallybio (NASDAQ:RLYB) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.26) by 19.23 percent. This is a 55.32 percent increase over losses of $(0.47) per share from the same
Benzinga Newsdesk

PRO
Rallybio Q4 EPS $(0.25) Beats $(0.29) Estimate, Sales $38.00K Miss $75.00K Estimate

Rallybio (NASDAQ:RLYB) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.29) by 13.79 percent. This is a 50 percent increase over losses of $(0.50) per share from the same
Benzinga Newsdesk

PRO
Rallybio Q3 EPS $(0.26) Beats $(0.37) Estimate, Sales $299.00K

Rallybio (NASDAQ:RLYB) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.37) by 29.73 percent. This is a 42.22 percent increase over losses of $(0.45) per share from the same
Benzinga Newsdesk

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved